Boehringer Ingelheim opens Health Management Centre in China
The new Health Management Centre integrates animal disease and health diagnostics as well as monitoring tools to maintain and enhance animal health.
Boehringer Ingelheim Vetmedica GmbH
web:http://www.boehringer-ingelheim.com/products/animal_health.html
Phone:+49 - 6132 - 77 0
Country:Germany
Boehringer Ingelheim and Harbin Veterinary Research Institute set up ‘industry-academia-research’ exchange platform
It is the first comprehensive ‘industry-academia-research’ exchange platform jointly set up by an agricultural research institute and a multinational animal health company in China.
Boehringer Ingelheim acquires stake in SoundTalks, begins pilot programme
Boehringer Ingelheim plans a pilot programme using the innovative SoundTalksTM system in select pig barns. The goal is to harness the power of digital innovation and technological change to detect possible respiratory distress in swine quickly
Boehringer Ingelheim and Dopharma complete the acquisition of Saint-Herblon production site
This sale is part of Boehringer Ingelheim Animal Health’s strategic refocusing on advanced and preventive animal healthcare; Saint-Herblon mainly producing generics and antibiotics for livestock, under the Coophavet brand.
Boehringer Ingelheim and GNA Biosolutions partner on emergency veterinary diagnostics development
Programme could lead to new diagnostic solutions for African swine fever.
Boehringer Ingelheim launches first veterinary vaccines produced in China
The first local manufacturing plant, wholly-owned by a multinational animal health company, focuses on the China swine market.
Boehringer Ingelheim launches a tool to aid in the prevention of African swine fever
This tool enables pig producers to evaluate areas for biosecurity improvement on their farms.
Boehringer Ingelheim announces a pre-signing with Dopharma for the acquisition of its production site in Saint-Herblon, France
Dopharma is a growing player on the market, already distributing in more than 50 countries.
Boehringer Ingelheim inaugurates its new global centre for veterinary vaccine R&D in Lyon, France
The new R&D center of 14,500 square meters is a high-tech facility employing more than 200 employees.
Boehringer Ingelheim invests more than €200 million to establish strategic production center for Veterinary Public Health in France
With this new site, the company will be able to respond to the growing global demand for foot-and-mouth disease and Bluetongue virus control.
Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry
The 11th Expert Forum on Farm Animal Well-Being will bring together over 100 veterinary practitioners and welfare specialists.
Boehringer Ingelheim inaugurates its new integrated Asian Veterinary Research & Development Centre
World-class research & development facility of 3,300 square meters will help enhance China’s animal health industry.
Three leading animal health companies join hands to launch world-class vaccine joint venture targeting foot-and-mouth disease in China
Boehringer Ingelheim, KMOH, and ZNWT establish a vaccine joint venture targeting foot-and-mouth disease control and prevention in China.
2018 European PRRS Research Award open for submissions until July 1st
Boehringer Ingelheim funds three research projects against swine disease PRRS with a total of €75,000
Boehringer Ingelheim Invests $80 Million to Expand Animal Vaccine Manufacturing Capacity in the U.S.
Investments in Athens, GA and St. Joseph, MO will enable increased capacity for companion animal and livestock vaccines.
Winners of the 2017 European PRRS Research Award announced
Boehringer Ingelheim Animal Health sponsors the €75,000 research award programme in Europe both to encourage further development of practical methods for controlling PRRS and in order to recognise scientific excellence in this field.
Comprehensive online management biosecurity assessment tool
New tool is part of suite of solutions to improve farm biosecurity and control of PRRS (Porcine Reproductive and Respiratory Syndrome).
Boehringer Ingelheim: A New World Leader in Animal Health
Animal health business, following a positive 2016, is poised for strong long-term growth and industry leadership after strategic addition of Merial.
Boehringer Ingelheim presents a new tool to assess and monitor biosecurity and management risks in pig farms
Biosecurity in pig farms plays a key role in PRRS control and some of the recommendations depend on the movement and flow of certain pathogen-carrying agents like people or objects.
Boehringer Ingelheim Animal Health has been supporting independent research on PCV2 for one decade
Over the past ten years, 29 research projects have been awarded with € 25,000.
2017 European PRRS Research Award: Boehringer Ingelheim Animal Health calls for submissions until July 1st
Boehringer Ingelheim Animal Health funds three research projects for improved control of swine disease PRRS with a total of 75,000 euros